National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

News & Events
 News Releases
  2009
  2008
  2007
  2006
  2005
  2004
  2003
  2002
  2001
  2000
  1999
  1998
  1997
  1996
  1995
  By Topic
 Qs & As
 Media Inquiries
 Events & Calendars
 NIAID in the News
 Resources



On the Death of Martin Delaney
January 23, 2009


Statement of Anthony S. Fauci, M.D.
Director, National Institute of Allergy and Infectious Diseases
National Institutes of Health



Martin Delaney, the founder and longtime director of the HIV advocacy/education organization Project Inform, died of liver cancer at his home near San Francisco on January 23, 2009. Mr. Delaney was 63.  

Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), said, “The NIAID community is deeply saddened by the death of Martin Delaney, a true hero in the fight against HIV. Marty worked tirelessly as an advocate for HIV-infected people, and made enormous contributions to framing and advancing the HIV/AIDS research effort at NIAID and elsewhere. His life is a testament to the power of committed advocacy and activism to advance public health.”

Dr. Fauci added, “I worked closely with Marty for nearly a quarter century and will greatly miss his astute insights and advice. Many others at NIAID involved in the HIV/AIDS research effort also have benefited from his well-informed wisdom and counsel. The Institute and the AIDS community at large have lost an important colleague and a good friend.”

Mr. Delaney was a member of the NIAID AIDS Research Advisory Committee from 1991 to 1995, served on NIAID’s National Advisory Allergy and Infectious Disease Council from 1995 to 1998, and also served in other advisory roles for the Institute. In addition, Mr. Delaney was a founding member of the U.S. Department of Health and Human Services panel that writes guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents.

On January 19, 2009, Mr. Delaney received the NIAID Director’s Special Recognition Award for “extraordinary contributions to framing the HIV research agenda, particularly with regard to antiretroviral drugs and access to treatment; exceptional efforts on behalf of HIV-infected people; and wise counsel while serving on NIAID advisory committees.”

Dr. Fauci is director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health in Bethesda, Maryland.

Media inquiries can be directed to the NIAID Office of Communications at 301-402-1663, niaidnews@niaid.nih.gov.


NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.



E-mail update Receive notifications by e-mail when NIAID press releases update.

See Also

Media Contact Info

News Releases by Topic

Health & Research Topics


NIH Logo

The National Institute of Allergy and Infectious Diseases is a component of the National Institutes of Health, U.S. Department of Health and Human Services

NIAID Logo

 
Print Icon Print this page
E-mail Icon E-mail this page

E-mail update Receive notifications by e-mail when NIAID press releases update.

See Also

Media Contact Info

News Releases by Topic

Health & Research Topics